Calcium Carbonate Oral Suspension
- Manufacturer
- Major Pharmaceuticals | Plastikon Healthcare | Plastikon Healthcare, LLC
- Effective date
- 2020-02-14
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 2
- Source
- legacy-cache
- Hydrated at
- 2026-08-01 23:36:41
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
Major Pharmaceuticals Calcium Carbonate Oral Suspension, USP 5 mL unit dose cup
NDC 0904-6842-94
Calcium Carbonate
Oral Suspension, USP
1250 mg/5 mL
(equivalent to 500 mg of elemental Calcium)
Delivers 5 mL
Antacid - Shake Well
See Insert
For Institutional Use Only
Major Pharmaceuticals
Livonia, MI 48152
Sugar Free - Alcohol Free
Calcium Carbonate Oral Suspension IFU 5 mL
Calcium Carbonate Oral Suspension
Directions
- do not exceed the maximum recommended daily dose in a 24-hour period
- do not use the maximum dosage for more than 2 weeks
- shake well before use
Dose (mL)
5-10 mL as symptoms occur
Do not take more than 30 mL in 24 hours.
Calcium Carbonate Oral Solution
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away. (1-800-222-1222)
Calcium Carbonate Oral Solution
Warnings
Ask a doctor or pharmacist before use if you are taking any other drug. Antacids may interact with certain prescription drugs.
___________________________________________________________________
If pregnant or breast-feeding, ask a health professional before use.
Calcium Carbonate Oral Solution
Inactive ingredients cherry flavor, citric acid, glycerin, methyl cellulose, methyl paraben, propyl paraben, purified water, sorbitol, sucralose, xanthan gum.
Calcium Carbonate Oral Solution
Active ingredient (in each 5 mL cup)
Calcium Carbonate 1250 mg
(Equivalent to 500 mg elemental Calcium)
Calcium Carbonate Oral Solution
Purpose
Antacid
Calcium Carbonate Oral Solution
Other information
- store at 20-25°C (68-77°F)
- protect from excessive moisture
- do not use if lid seal is open or damaged
- sugar free, dye free, alcohol free
- see bottom of cup for lot number and expiration date
Questions or comments?
Call 1-800-616-2471
Calcium Carbonate Oral Suspension
Uses
relieves heartburn
relieves acid indigestion
relieves sour stomach
relieves upset stomach associated with these symptoms
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 0904-6842-94 | 2024-11-19 | C162847 | 48780-1 | d6a99b39-eff0-a426-e053-dadaa90af4c2 | Calcium Carbonate Oral Suspension, USP 5 mL single dose cup Major Pharmaceuticals |
| 0904-6842-94 | 2022-01-28 | C162847 | 48780-1 | d6a99b39-eff0-a426-e053-dadaa90af4c2 | Calcium Carbonate Oral Suspension, USP 5 mL single dose cup Major Pharmaceuticals |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0904-6842-94 | ML - Milliliter | 0904-6842 | 3d400e1f-a365-452d-a57c-247b8e5df9c1 | 1 | 2020-03-10 |
Products#
Every source-derived product name is available through these pages.
- Calcium Carbonate Oral Suspension
- Calcium Carbonate
- CALCIUM CATION
- GLYCERIN
- SUCRALOSE
- XANTHAN GUM
- ANHYDROUS CITRIC ACID
- METHYLPARABEN
- PROPYLPARABEN
- METHYLCELLULOSE, UNSPECIFIED
- SORBITOL
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 0904-6842 | 0904-6842-94 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| CALCIUM CARBONATE | H0G9379FGK | ACTIM |
| GLYCERIN | PDC6A3C0OX | IACT |
| SUCRALOSE | 96K6UQ3ZD4 | IACT |
| XANTHAN GUM | TTV12P4NEE | IACT |
| ANHYDROUS CITRIC ACID | XF417D3PSL | IACT |
| METHYLPARABEN | A2I8C7HI9T | IACT |
| PROPYLPARABEN | Z8IX2SC1OH | IACT |
| METHYLCELLULOSE, UNSPECIFIED | Z944H5SN0H | IACT |
| SORBITOL | 506T60A25R | IACT |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 1c8940f1-53ba-4f30-9cd2-0ec05f9416e9 | 9b30c7d4-d36d-31ee-e053-2a95a90ac5ab | 2024-11-15 | Warnings | 9b30c7d4-d36d-31ee-e053-2a95a90ac5ab |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.

